US7995661045
US7995661045
Sana Biotechnology, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 835.22M EUR | 1.04B EUR | 777.07M EUR | 1.09B EUR |
Enterprise Value | 755.67M EUR | 1.06B EUR | 768.6M EUR | 1.09B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -5.03x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 5.41x | 6.76x | 6.52x | 6.75x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -4.34x | -- | -- | -- |
Price to FCF (P/FCF) | 202.45x | -- | -- | -- |
EV/FCF | 183.16x | -- | -- | -- |
FCF Yield | 0.49% | -12.93% | -17.2% | -8.84% |